Lv1
30 积分 2024-01-25 加入
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
19天前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
19天前
已关闭
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
24天前
已完结
IGSF8 is an innate immune checkpoint and cancer immunotherapy target
1个月前
已完结
CD24 blockade as a novel strategy for cancer treatment
4个月前
已完结
皖公网安备34019202002308
